| Literature DB >> 19098994 |
Wei Fen Gong1, Sylvia W Y Chiang, Li Jia Chen, Pancy O S Tam, Li Yun Jia, Dexter Y L Leung, Yi Qun Geng, Clement C Y Tham, Dennis S C Lam, Robert Ritch, Ningli Wang, Chi Pui Pang.
Abstract
PURPOSE: The lysyl oxidase-like protein 1 (LOXL1) gene is strongly associated with exfoliation glaucoma, which is very rare in the Chinese population. The implicated LOXL1 polymorphisms have not been associated with primary open-angle glaucoma (POAG). In this study, we investigated three of the LOXL1 polymorphisms in POAG in a southern Chinese population of Hong Kong and northern Chinese from Beijing.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19098994 PMCID: PMC2605423
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Demographic features of the study populations.
| Female (%) | 117 (39.9) | 127 (50.8) | 37 (21.9) | 100 (50.8) |
| Age range | 15–88 | 60–99 | 8–82 | 60–89 |
| Mean age (SD) years | 66.8 (12.9) | 74.1 (6.8) | 39.1 (16.5) | 69.4 (6.0) |
Primer sequences and PCR conditions for LOXL1 polymorphisms.
| F:CCAGGTGCCCGACAACTGG | 1.5 | 60 | 239 | |
| | R:AACCCTGGTCGTAGGTCCGC | |||
| F:TCTAGGGCCCCTTGGAGAATAGG | 1.5 | 60 | 341 | |
| R:AACTGTGGGGCTCAGGGTAGTGG |
The asterisk indicates that SNPs, rs1048661 and rs3825942, were located in the same amplicon.
Distribution of LOXL1 polymorphisms in the Hong Kong cohort.
| T | 340 (58.0) | 264 (52.8) | 0.084 | TT | 109 (37.2) | 69 (27.6) | 0.047 | |
| | G | 246 (42.0) | 236 (47.2) | | GT | 122 (41.6) | 126 (50.4) | |
| | | | | | GG | 62 (21.2) | 55 (22.0) | |
| G | 524 (89.4) | 438 (87.6) | 0.35 | GG | 237 (80.9) | 193 (77.2) | 0.54 | |
| | A | 62 (10.6) | 62 (12.4) | | GA | 50 (17.1) | 52 (20.8) | |
| | | | | | AA | 6 (2.0) | 5 (2.0) | |
| C | 537 (91.6) | 449 (89.8) | 0.3 | CC | 246 (84.0) | 199 (79.6) | 0.14 | |
| | T | 49 (8.4) | 51 (10.2) | | CT | 45 (15.4) | 51 (20.4) | |
| TT | 2 (0.7) | 0 (0.0) | ||||||
Distribution of LOXL1 polymorphisms in the Beijing cohort.
| T | 176 (52.1) | 198 (50.3) | 0.62 | TT | 42 (24.9) | 48 (24.4) | 0.77 | |
| | G | 162 (47.9) | 196 (49.7) | | GT | 92 (54.4) | 102 (51.8) | |
| | | | | | GG | 35 (20.7) | 47 (23.9) | |
| G | 304 (89.9) | 341 (86.5) | 0. 16 | GG | 136 (80.5) | 146 (74.1) | 0.35 | |
| | A | 34 (10.1) | 53 (13.5) | | GA | 32 (18.9) | 49 (24.9) | |
| | | | | | AA | 1 (0.6) | 2 (1.0) | |
| C | 309 (91.4) | 361 (91.6) | 0.92 | CC | 141 (83.4) | 164 (83.2) | 0.55 | |
| | T | 29 (8.6) | 33 (8.4) | | CT | 27 (16.0) | 33 (16.8) | |
| TT | 1 (0.6) | 0 (0.0) | ||||||
Haplotype analysis of LOXL1 SNPs in POAG in the Hong Kong cohort.
| H1 | T | G | C | 0.558 | 0.524 | 0.278 | 0.00336 | 1.15 (0.91–1.46) |
| H2 | G | G | C | 0.257 | 0.25 | 0.808 | 0.000419 | 1.03 (0.78–1.36) |
| H3 | G | A | C | 0.101 | 0.124 | 0.253 | 0.000756 | 0.80 (0.55–1.16) |
| H4 | G | G | T | 0.063 | 0.098 | 0.0249 | 0.00347 | 0.62 (0.40–0.97) |
| H5 | T | G | T | 0.021 | 0.004 | 0.00108 | 0.058 | 5.24 (1.17–23.54) |
All haplotypes with frequency greater than 1% were shown in the table. HS test represented haplotype-specific test, and SVH test represents haplotype-based sole-variant test. The p values from the HS test were corrected by a permutation test by 1000 times of iterations. Omnibus χ2=18.16 (df=4); p=0.00115, Pperm=0.00399; n=293 case and n=250 control subjects.
Haplotype analysis of LOXL1 SNPs in POAG in the Beijing cohort.
| B1 | T | G | C | 0.521 | 0.503 | 0.612 |
| B2 | G | G | C | 0.298 | 0.279 | 0.578 |
| B3 | G | A | C | 0.098 | 0.135 | 0.117 |
| B4 | G | G | T | 0.083 | 0.084 | 0.982 |
| B5 | T | G | T | - | - | - |
The B5 haplotype, although not detected in the Beijing cohort, was listed in the table to make a comparison with the Hong Kong cohort in Table 5. The SVH test was not done in the Beijing cohort because of the non-significant omnibus association. Omnibus X2=2.525 (df=3); p=0.471. n=169 case and n=197 control subjects.
Summary of the reported allele frequencies of the LOXL1 polymorphisms in POAG.
| Iceland | Control | 0.651 | 0.847 | 0.473 | 14474 | [ |
| | POAG | 0.711 | 0.872 | 0.55 | 90 | |
| Sweden | Control | 0.682 | 0.879 | 0.535 | 198 | [ |
| | POAG | 0.638 | 0.863 | 0.488 | 200 | |
| U.S Caucasian | Control | 0.719 | 0.795 | 0.456 | 88 | [ |
| | POAG | 0.724 | 0.771 | 0.412 | 331 | |
| African American | Control | NA | 0.599 | 0.204 | 97 | [ |
| | POAG | NA | 0.617 | 0.237 | 193 | |
| India | Control | 0.695 | 0.75 | 0.32 | 105 | [ |
| | POAG | 0.616 | 0.83 | 0.325 | 112 | |
| Japan | Control | 0.493 | 0.877 | 0.058 | 138 | [ |
| | POAG | 0.395 | 0.911 | 0.048 | 60 | |
| Southern China | Control | 0.472 | 0.876 | 0.102 | 250 | Present study |
| | POAG | 0.42 | 0.894 | 0.084 | 293 | |
| Northern China | Control | 0.497 | 0.865 | 0.084 | 197 | Present study |
| POAG | 0.479 | 0.899 | 0.086 | 169 | ||
Allele frequencies of rs1048661 G, rs3825942 G, and rs2165241 T in POAG cases and controls among different populations were displayed in the table. In the referred studies [21,23,30,33,34] and in our present study, the SNPs were not significantly associated with POAG individually. NA: not available.